The global gene amplification technologies market value was US$ 26.25 billion in 2020. The global gene amplification technologies market value is forecast to reach US$ 35.3 billion by 2030, growing at a compound annual growth rate (CAGR) of 3% during the forecast period from 2021-2030.
Gene amplification is one of the most important techniques used in genomic research, and it plays a crucial role in several other applications, including diagnostics. There are many gene- and signal-amplification mechanisms, such as polymerase chain reaction, ligase chain reaction, transcription-mediated amplification, and dendritic polymers. Research and clinical settings utilize these technologies widely.
Factors Influencing Market Growth
Increasing research and development across molecular diagnostics, genomics, biological research, and genetic testing are critical factors driving the global market.
The primary driving force of the global market is the constantly expanding landscape of advanced DNA multiplication technologies. As a result of technological advancements related to loop-mediated amplification, substitutes, and advanced technologies such as Nucleic Acid Sequence Based Amplification (NASBA), NASBA has become more popular.
The application of gene amplification and vector engineering is driving the demand for the gene amplification technologies market. Gene amplification technologies are also likely to increase revenue by helping diagnose inherited, infectious, and systemic diseases.
Impact Analysis of COVID-19
The COVID-19 pandemic has positively impacted the global gene amplification technologies market. Several COVID-19 diagnostic tests are continuously developed based on different gene amplification methods. In addition, the availability of many new products and technological advances has enhanced the ability to diagnose COVID-19 in the POC setting in an accurate and quick manner. Additionally, PCR is generating significant revenue through its use in the large-scale detection of COVID-19.
Regional Insights
In 2020, North America held dominance in the global market, with the highest revenue share. Among the key factors contributing to the growth of the North America market include research and a commercial base for gene multiplication products and active genetic research programs in the region. Many companies providing gene amplification solutions (instruments, kits, and reagents) have their headquarters in the U.S. This factor has also contributed to the region's high revenue generation.
The Asia Pacific region is forecast to grow the fastest during the forecast period due to government initiatives to develop healthcare infrastructure. In emerging economies, such as China and India, both genomics and molecular diagnostics research and the availability of skilled labor have augmented market growth. For example, Chinese researchers developed a rapid and ultrasensitive ELISA test in April 2021 that incorporated rolling circle amplification for the early diagnosis of various diseases.
Leading Competitors
The leading prominent companies profiled in the global gene amplification technologies market are:
4basebio AG
Bio-Rad Laboratories
Danaher Corporation
Illumina Inc.
LGC Group
Merck KGaA
MyBioSource
New England Biolabs
Promega Corporation
QIAGEN
Silicon Biosystems
Takara Bio Inc.
Vazyme Biotech Co. Ltd.
Yikang Gene
Other Prominent Players
Scope of the Report
The global gene amplification technologies market segmentation focuses on Technology, Downstream, Sample Type, Product, End-use, and Region.
Segmentation based on Technology
PCR-based Amplification
Loop-mediated Isothermal Amplification
Nucleic Acid Sequence Based Amplification
Strand Displacement Amplification
Multiple Displacement Amplification
Rolling Circle Amplification
Ramification Amplification
Others
Segmentation based on Downstream
Whole Genome Amplification
Exome Sequencing
SNP Genotyping Arrays
Array CGH
Hybridization
Others
Segmentation based on Sample Type
Single Cell
FFPE
Others
Segmentation based on Product
Instruments
Kits & Reagents
Services
Segmentation based on End-use
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Others
Segmentation based on Region
North America
o The U.S.
o Canada
o Mexico
Europe
? Western Europe
o The UK
o Germany
o France
o Italy
o Spain
o Rest of Western Europe
? Eastern Europe
o Poland
o Russia
o Rest of Eastern Europe
Asia Pacific
o China
o India
o Japan
o Australia & New Zealand
o ASEAN
o Rest of Asia Pacific
Middle East & Africa (MEA)
o UAE
o Saudi Arabia
o South Africa
o Rest of MEA
South America
o Brazil
o Argentina
o Rest of South America

Meta Title: Gene Amplification Technologies Market Share, Size, Growth, Insights, Trends and Forecast by 2030
Meta Description: The global gene amplification technologies market value is forecast to reach US$ 35.3 billion by 2030, growing at a compound annual growth rate (CAGR) of 3% during the forecast period from 2021-2030.
Meta Keywords: Gene Amplification Technologies Market, Gene Amplification Technologies Market Trends, Gene Amplification Technologies Market Size, Gene Amplification Technologies Market Share, Gene Amplification Technologies Market Insights, Gene Amplification Technologies Market Forecast